quantisnow
FeedTopReportsPricing
⌘K
Live feed
19:32:57·785d
INSIDERFiling
Rover Group Inc. logo

Madrona Venture Fund Iv, Lp acquired 423,063 shares and disposed of $295,756,769 worth of shares (26,886,979 units at $11.00) (SEC Form 4)

ROVR· Rover Group Inc.
Consumer Discretionary
Original source

Companies

  • ROVR
    Rover Group Inc.
    Consumer Discretionary

Recent analyst ratings

  • Aug 9UpdateGordon Haskett$3.50
  • Jul 15UpdateGoldman$4.50
  • Jul 7UpdateJP Morgan$5.00
  • Mar 8UpdateMorgan Stanley$6.00
  • Mar 8UpdateCanaccord Genuity$8.00
  • Mar 8UpdateJMP Securities$11.00

Related

  • SEC776d
    SEC Form 15-12G filed by Rover Group Inc.
  • 13D/G784d
    SEC Form SC 13D/A filed by Rover Group Inc. (Amendment)
  • 13D/G785d
    SEC Form SC 13D/A filed by Rover Group Inc. (Amendment)
  • INSIDER785d
    Prusch Erik converted options into 54,855 shares and returned $603,405 worth of shares to the company (54,855 units at $11.00) (SEC Form 4)
  • INSIDER785d
    Leslie Kristina M returned $1,136,278 worth of shares to the company (103,298 units at $11.00) and converted options into 33,273 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER785d
    Wickers Charles disposed of 32,874 shares and returned $1,106,446 worth of shares to the company (100,586 units at $11.00), closing all direct ownership in the company (SEC Form 4)
  • INSIDER785d
    Jacobson Scott was granted 423,063 shares and returned $295,756,769 worth of shares to the company (26,886,979 units at $11.00) (SEC Form 4)
  • INSIDER785d
    Cohen Jamie converted options into 66,550 shares and returned $991,276 worth of shares to the company (90,116 units at $11.00), closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022